Let's be honest, these mistakes are easy to make, but they are also completely avoidable
In two identical phase 3 randomized, placebo-controlled trials (RECONNECT, 1,267 premenopausal women with hypoactive sexual desire disorder), bremelanotide produced statistically significant improvements in sexual desire and reductions in desire-related distress versus placebo, which led to FDA approval (as Vyleesi) for that specific population (Kingsberg et al., Obstet Gynecol 2019)
Frequently Asked Questions What is in each vial
While the treatment didnt change the levels of a key reproductive hormone in the brain, it did increase the levels of another hormone that stimulates testosterone production
Similar content being viewed by others 1 Introduction Alzheimer's disease (AD) is rapidly increasing in frequency globally as the world population ages
Research indicates improvements in body weight, appetite control, and metabolic health outcomes in individuals with obesity
